Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KRTL Biotech
Lakewood, Colorado, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
KRTL Biotech facilitates FDA registration for international manufacturers, enables U.S. market entry for drugs and APIs, leads in pharmaceutical integration between Latin America (notably Bolivia) and the U.S., and deploys proprietary mobile extraction for cannabis and psilocybin; it is not primarily developing novel NCE drug candidates itself, but rather enabling commercialization for clients and partners
- Therapeutic areas
- ImmunologyNeurologyDermatologyPsychiatry
- Modalities
- Small moleculeBiologicCannabis derivative
- Industry
- Consulting
02
Partnerships
Industria Químico Farmaceutica SIGMA CORP. S.R.L. ("SIGMACORP")CIQEntexsIron Sight
Beyond the preview
Go deeper on KRTL Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KRTL Biotech.